The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Sales share of AbbVie's three major drugs from 2020 to 2025
AbbVie's major three drug sales share 2025
In 2025, Skyrizi, Rinvoq, and Humira were the three major products of AbbVie. The sales share of the three major drugs was close to 50 percent. AbbVie is a U.S.-based global pharmaceutical and healthcare products company, headquartered in Chicago, Illinois.Â
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Biopharmaceutical industry impact on labor income U.S. 2022
- Basic Statistic Biopharmaceutical industry impact on output U.S. 2022
- Basic Statistic Biopharmaceutical industry impact on added value U.S. 2022
- Basic Statistic Number of startups using AI in drug discovery worldwide 2019, by area of discovery
- Basic Statistic AbbVie's R&D expenditures as revenue share 2012-2024
- Basic Statistic Projection of top therapeutic areas by sales worldwide 2019
- Premium Statistic Leading pharmaceutical companies' SG&A to revenue rate 2024
- Basic Statistic Impact of U.S. biopharmaceutical industry on employment 2022
- Premium Statistic Top 10 global pharmaceutical companies by revenue 2025
- Premium Statistic Percentage return on R&D among large cap biopharma companies 2010-2020
About the region
10
- Basic Statistic Projection of top global pharmaceutical products by revenue growth 2023
- Basic Statistic Amgen operating income 2016-2025
- Basic Statistic Leading pharmaceutical drugs worldwide H1 2025, by sales
- Premium Statistic Global biotechnology market share by region 2012
- Basic Statistic Percentage return on R&D among mid cap biopharma companies 2013-2020
- Premium Statistic Total value of biopharma M&A deals worldwide from 2010 to 2019, by top companies
- Basic Statistic Average deal value of biopharma M&A deals worldwide 2010-2019, by top companies
- Basic Statistic Impact of the U.S. biopharmaceutical industry on federal personal tax revenues 2022
- Basic Statistic Amgen dividends paid 2011-2024
- Basic Statistic Amgen property, plant and equipment 2022-2024
Selected statistics
10
- Basic Statistic AbbVie revenue 2010-2025
- Basic Statistic AbbVie net earnings 2010-2025
- Premium Statistic AbbVie's revenue by therapy area 2022-2025
- Premium Statistic Top U.S. pharmaceutical patent expiries by revenue 2014-2016
- Basic Statistic Projected top pharmaceutical companies based on new sales 2023
- Basic Statistic Market capitalization change in key COVID-19 firms until end-May 2020
- Basic Statistic Leading pharma and biotech companies in 2024, by net sales growth
- Premium Statistic Leading global biotech and pharmaceutical companies 2026, by net income
- Basic Statistic Projected top pharmaceutical companies based on sales 2023
- Basic Statistic Enterprise value change in biopharma subsectors worldwide 2025-2026
Other regions
10
- Basic Statistic Biotech firms active in COVID-19 R&D in Italy 2020, by product
- Premium Statistic Total VC investment worldwide in biotech industry 2010-2019
- Premium Statistic Employment in Bay Area health care & social assistance industry 2014-2024
- Premium Statistic Employment in South California's health care & social assistance industry 2014-2024
- Basic Statistic Employment in L.A. County health care & social assistance industry 2014-2024
- Premium Statistic Employment in Californian health care & social assistance industry 2014-2024
- Premium Statistic Biotechnology companies in Germany from 2014 to 2018 by state
- Premium Statistic Employees in biotechnology companies in Germany from 2014 to 2018 by state
- Basic Statistic Drug products patented sales share in Canada, by therapeutic class 2022
- Premium Statistic Biotechnology companies size in Germany from 2005 to 2009 by employees
Related statistics
10
- Premium Statistic Bayer Group's major three drug sales share 2021-2025
- Basic Statistic AstraZeneca's major three drug sales share 2021-2025
- Premium Statistic Estimated average growth of major pharmaceutical companies 2026-2030
- Premium Statistic Bristol-Myers Squibb's operating cash flow 2015-2025
- Premium Statistic Bristol-Myers Squibb's major three drug sales share 2021-2025
- Premium Statistic Eli Lilly's three major pharmaceutical drugs 2021-2025, by sales share
- Premium Statistic Output of the pharmaceutical industry worldwide 2024-2027, by region
- Premium Statistic Projects in the pipeline of Novartis AG Q4 2025, by phase
- Premium Statistic Free cash flow of Novartis AG 2016-2025
- Basic Statistic Free cash flow of the Roche Group 2015-2025
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
AbbVie, & U.S. Securities and Exchange Commission. (February 20, 2026). Sales share of AbbVie's three major drugs from 2020 to 2025 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 26, 2026, from /statistics/1660782/abbvie-s-major-three-drug-sales-share/
AbbVie, und U.S. Securities and Exchange Commission. "Sales share of AbbVie's three major drugs from 2020 to 2025." Chart. February 20, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 26, 2026. /statistics/1660782/abbvie-s-major-three-drug-sales-share/
AbbVie, U.S. Securities and Exchange Commission. (2026). Sales share of AbbVie's three major drugs from 2020 to 2025. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 26, 2026. /statistics/1660782/abbvie-s-major-three-drug-sales-share/
AbbVie, and U.S. Securities and Exchange Commission. "Sales Share of Abbvie's Three Major Drugs from 2020 to 2025." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 20 Feb 2026, /statistics/1660782/abbvie-s-major-three-drug-sales-share/
AbbVie & U.S. Securities and Exchange Commission, Sales share of AbbVie's three major drugs from 2020 to 2025 ÌÇÐÄÆƽâ°æ, /statistics/1660782/abbvie-s-major-three-drug-sales-share/ (last visited July 26, 2026)
Sales share of AbbVie's three major drugs from 2020 to 2025 [Graph], AbbVie, & U.S. Securities and Exchange Commission, February 20, 2026. [Online]. Available: /statistics/1660782/abbvie-s-major-three-drug-sales-share/
Advertisement